Eli Lilly drops as FDA decision on weight loss pill is now expected in April

Eli Lilly (LLY) stock slips as the FDA decision on the company's obesity pill orforglipron is now due in April, which ...

France denies contact with Eli Lilly over reported $17.5 bln Abivax deal

France's Finance ​Ministry said on Monday it had received no formal request for investment approval ‌regarding French biotech ...

Popular weight-loss drugs shouldn’t carry suicide warnings, FDA says

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
STAT

FDA delays reviews for two drugs in new voucher program

Today, we discuss Trump’s lofty new health plan, see the FDA delay two drug reviews under the new voucher program, and more.

US FDA requests removal of suicide warnings from weight-loss drugs

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...
MarketBeat on MSN

Eli Lilly stock rallies as Ventyx deal calms Wegovy concerns

In the last few months of 2025, shares of pharmaceutical giant Eli Lilly and Company (NYSE: LLY) went on an undeniable hot ...
WRTV

Drug companies pay Indiana doctors to talk about GLP-1 drugs, records show

Pharmaceutical companies are paying thousands of Indiana doctors to talk about GLP-1 drugs, a WRTV Investigation has ...